Department of Breast Surgery, Nagoya City University Graduate School of Medical Sciences, 1, Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Aichi, Japan.
Department of Breast and Endocrine Surgical Oncology, Tohoku University School of Medicine, Sendai, Japan.
Breast Cancer. 2022 Jul;29(4):698-708. doi: 10.1007/s12282-022-01348-y. Epub 2022 Mar 22.
Occult breast cancer (OBC) is classified as carcinoma of an unknown primary site, and the adequate therapy for OBC remains controversial. This retrospective study aimed to reveal the transition in breast cancer therapy and the frequency of primary breast tumors after resection in clinical OBC (cT0N+) patients using the Japanese Breast Cancer Registry database.
We enrolled OBC patients with cT0N+ from the registry between 2010 and 2018. On the basis of the period of diagnosis, OBC patients were divided into the following two groups: 2010-2014 and 2015-2018. We described the transition in treatments and tumor characteristics. After breast resection, the frequency of pathological identification of primary tumors and tumor sizes was assessed.
Of the 687,468 patients registered, we identified 148 cT0N+ patients with a median age of 61 years. Of these patients, 64.2% (n = 95) received breast surgery (2010-2014: 79.1%, 2015-2018: 50.0%). Axillary lymph node dissection was performed in 92.6% (n = 137, 2010-2014: 91.6%, 2015-2018: 93.4%). The breast tumor size in the resected breast was 0-7.0 cm (median: 0 cm, 2010-2014: 0-7.0 cm [median: 0 cm], 2015-2018: 0-6.2 cm [median: 0 cm]). The pathological identification rate of the primary tumor was 41.1% (n = 39, 2010-2014: 40.4%, 2015-2018: 42.1%).
Breast surgery for cT0N+ decreased between 2010 and 2018. Despite the high identification rate of primary tumors, most tumors were small, and there was no significant change in the identification rate or invasive diameter of the identified tumors after 2010.
隐匿性乳腺癌(OBC)被归类为不明原发灶的癌,OBC 的适当治疗仍存在争议。本回顾性研究旨在利用日本乳腺癌登记数据库揭示临床隐匿性乳腺癌(cT0N+)患者的乳腺癌治疗转变以及切除后原发性乳腺肿瘤的发生频率。
我们招募了 2010 年至 2018 年登记处的 cT0N+OBC 患者。根据诊断时间,OBC 患者分为以下两组:2010-2014 年和 2015-2018 年。我们描述了治疗方法的转变和肿瘤特征。乳房切除术后,评估原发性肿瘤的病理识别频率和肿瘤大小。
在登记的 687468 名患者中,我们确定了 148 名 cT0N+患者,中位年龄为 61 岁。其中,64.2%(n=95)接受了乳房手术(2010-2014 年:79.1%,2015-2018 年:50.0%)。92.6%(n=137)行腋窝淋巴结清扫术(2010-2014 年:91.6%,2015-2018 年:93.4%)。切除乳房中的乳腺肿瘤大小为 0-7.0cm(中位数:0cm,2010-2014 年:0-7.0cm[中位数:0cm],2015-2018 年:0-6.2cm[中位数:0cm])。原发性肿瘤的病理识别率为 41.1%(n=39,2010-2014 年:40.4%,2015-2018 年:42.1%)。
2010 年至 2018 年间,cT0N+的乳房手术减少。尽管原发性肿瘤的识别率较高,但大多数肿瘤较小,2010 年后,识别肿瘤的比例或浸润直径无明显变化。